Marco Franza is Sales & Business Development Director – Global Inhalation & Medical Devices, at Berry Global Healthcare. He was previously Director, Sales, Marketing and Key Accounts at Plastiape, until it was acquired by Berry in 2019. Mr Franza has extensive experience in the commercial side of the drug delivery industry, having held roles related to sales, business development and marketing. His roles have had a particular focus on inhalation devices, which are both a key growth factor for the company and a passionate personal interest.
Frédérique Bordes-Picard of Lonza, Marco Franza of Berry, Mirjam Kobler of Meggle, and Marco Laackmann of Harro Höfliger, discuss the accelerating development potential of capsule-based dry powder inhalers (DPIs) and the potential of these effective and efficient drug delivery devices in the modern drug delivery market.